Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1231.65

-13.85 (-1.11%)

< Home < Back

Dr. Reddy's Lab gets EIR for formulations manufacturing plant in Hyderabad

Date: 20-05-2020

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA), for its Formulations Manufacturing Plant -3 at Bachupally, Hyderabad, indicating closure of the audit.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.